Literature DB >> 18303120

Mechanisms of high-glucose/insulin-mediated desensitization of acute insulin-stimulated glucose transport and Akt activation.

Katherine A Robinson1, Maria G Buse.   

Abstract

High-glucose/low-dose insulin-mediated insulin resistance of glucose transport was studied in 3T3-L1 adipocytes. In this model, proximal insulin signaling, including insulin receptor substrate (IRS)-1-bound phosphatidylinositol 3-kinase (PI 3-kinase) activation, is preserved, but insulin-stimulated protein kinase B (Akt) activation is markedly impaired. To assess a difference in acute insulin-stimulated production of phosphatidylinositol 3,4,5-trisphosphate [PtdIns(3,4,5)P3], cells were labeled with [32P]orthophosphate, and glycerophosphoinositides were quantified by HPLC. Although basal PtdIns(3,4,5)P3 was similar, insulin stimulated its production 33.6% more in controls (P < 0.03) than in insulin-resistant cells. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) protein, a lipid phosphatase that dephosphorylates PtdIns(3,4,5)P3 in the 3-position, was significantly and specifically increased in insulin-resistant cells. Treatment with rapamycin [a specific inhibitor of mammalian target of rapamycin complex 1 (mTORC1)] inhibited the increased PTEN expression and partially restored insulin-stimulated glucose transport and Akt activation to insulin-resistant cells. Acute insulin markedly stimulated Ser(636/639) phosphorylation of IRS-1; this was rapamycin inhibited but was significantly decreased in cells that had been preexposed to insulin, whereas total IRS-1 was unaffected. These findings were essentially paralleled by changes in the activation of p70 S6 kinase and S6-ribosomal protein. Overexpression of uncoupling protein-1 or manganese superoxide dismutase did not prevent the development of insulin-resistant glucose transport and impaired Akt activation in high-glucose/low-insulin-pretreated cells. The insulin resistance associated with glucotoxicity in our model reflects in part decreased availability of PtdIns(3,4,5)P3, which correlates with increased PTEN protein expression. Chronic activation of mTORC1 plays a role in stimulating PTEN expression and possibly in activation or induction of a phosphoprotein phosphatase. No evidence was found for a role for increased mitochondrial superoxide production in this model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303120      PMCID: PMC2703196          DOI: 10.1152/ajpendo.00644.2007

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  41 in total

1.  PTEN does not modulate GLUT4 translocation in rat adipose cells under physiological conditions.

Authors:  V A Mosser; Y Li; M J Quon
Journal:  Biochem Biophys Res Commun       Date:  2001-11-09       Impact factor: 3.575

2.  Development of glucose-induced insulin resistance in muscle requires protein synthesis.

Authors:  K Kawanaka; D H Han; J Gao; L A Nolte; J O Holloszy
Journal:  J Biol Chem       Date:  2001-03-27       Impact factor: 5.157

3.  Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1.

Authors:  Rachel Zhande; John J Mitchell; Jiong Wu; Xiao Jian Sun
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

4.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

5.  alpha-Lipoic acid prevents the development of glucose-induced insulin resistance in 3T3-L1 adipocytes and accelerates the decline in immunoreactive insulin during cell incubation.

Authors:  E L Greene; B A Nelson; K A Robinson; M G Buse
Journal:  Metabolism       Date:  2001-09       Impact factor: 8.694

6.  Insulin signalling and the regulation of glucose and lipid metabolism.

Authors:  A R Saltiel; C R Kahn
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

7.  Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site.

Authors:  X L Du; D Edelstein; S Dimmeler; Q Ju; C Sui; M Brownlee
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

8.  PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.

Authors:  Tianyan Gao; Frank Furnari; Alexandra C Newton
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

9.  A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1.

Authors:  T Haruta; T Uno; J Kawahara; A Takano; K Egawa; P M Sharma; J M Olefsky; M Kobayashi
Journal:  Mol Endocrinol       Date:  2000-06

10.  Ceramide dissociates 3'-phosphoinositide production from pleckstrin homology domain translocation.

Authors:  S Stratford; D B DeWald; S A Summers
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

View more
  13 in total

Review 1.  Linking mitochondrial bioenergetics to insulin resistance via redox biology.

Authors:  Kelsey H Fisher-Wellman; P Darrell Neufer
Journal:  Trends Endocrinol Metab       Date:  2012-02-02       Impact factor: 12.015

2.  Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.

Authors:  Alain Veilleux; Vanessa P Houde; Kerstin Bellmann; André Marette
Journal:  Mol Endocrinol       Date:  2010-03-04

3.  mTORC1 inhibition increases neurotensin secretion and gene expression through activation of the MEK/ERK/c-Jun pathway in the human endocrine cell line BON.

Authors:  Jing Li; Jianyu Liu; Jun Song; Xiaofu Wang; Heidi L Weiss; Courtney M Townsend; Tianyan Gao; B Mark Evers
Journal:  Am J Physiol Cell Physiol       Date:  2011-04-20       Impact factor: 4.249

4.  Deletion of Pten in pancreatic ß-cells protects against deficient ß-cell mass and function in mouse models of type 2 diabetes.

Authors:  Linyuan Wang; Yunfeng Liu; Shun Yan Lu; Kinh-Tung T Nguyen; Stephanie A Schroer; Akira Suzuki; Tak W Mak; Herbert Gaisano; Minna Woo
Journal:  Diabetes       Date:  2010-09-17       Impact factor: 9.461

5.  γ-Carboxyethyl hydroxychroman, a metabolite of γ-tocopherol, preserves nitric oxide bioavailability in endothelial cells challenged with high glucose.

Authors:  Youyou Li; Leena P Bharath; Ying Qian; Ting Ruan; Pon Velayutham Anandh Babu; Richard S Bruno; J David Symons; Thunder Jalili
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-28

6.  Arterial insulin resistance in Yucatan micropigs with diet-induced obesity and metabolic syndrome.

Authors:  Cecilia C Low Wang; Li Lu; J Wayne Leitner; Mohammad Sarraf; Roberto Gianani; Boris Draznin; Clifford R Greyson; Jane E B Reusch; Gregory G Schwartz
Journal:  J Diabetes Complications       Date:  2013-04-02       Impact factor: 2.852

Review 7.  Beta-cell failure as a complication of diabetes.

Authors:  K J Chang-Chen; R Mullur; E Bernal-Mizrachi
Journal:  Rev Endocr Metab Disord       Date:  2008-12       Impact factor: 6.514

Review 8.  Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes.

Authors:  Chin Fen Teo; Edith E Wollaston-Hayden; Lance Wells
Journal:  Mol Cell Endocrinol       Date:  2009-09-30       Impact factor: 4.102

9.  Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease.

Authors:  Satoru Matsuda; Mayumi Kobayashi; Yasuko Kitagishi
Journal:  ISRN Endocrinol       Date:  2013-01-30

10.  Insulin-dependent H2O2 production is higher in muscle fibers of mice fed with a high-fat diet.

Authors:  Alejandra Espinosa; Cristian Campos; Alexis Díaz-Vegas; José E Galgani; Nevenka Juretic; César Osorio-Fuentealba; José L Bucarey; Gladys Tapia; Rodrigo Valenzuela; Ariel Contreras-Ferrat; Paola Llanos; Enrique Jaimovich
Journal:  Int J Mol Sci       Date:  2013-07-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.